This CME/CE course explores central nervous system tumors, focusing on pediatric low-grade gliomas. Participants will gain insights into these tumors’ epidemiology, clinical presentation, histological subtypes, and their impact on neurological function. The course emphasizes the molecular drivers of low-grade gliomas, analyzing key genetic alterations and tumor progression mechanisms. It also highlights the role of precision medicine, including molecular profiling and targeted therapies, in advancing treatment strategies. Additionally, the course examines the challenges and opportunities in integrating precision medicine into clinical practice for managing central nervous system tumors. By completing this course, healthcare professionals will be better equipped to apply personalized treatment approaches, improving patient care and outcomes.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 50 Division Street
Pricing
CME included with membership
| Free CME Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Clinical Informatics
- Dermatology
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Pediatric Neurology
- Sleep Medicine
- Surgical Oncology
- Urological Oncology
- Vascular Neurology
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 0.5 credits
- $25
-
ReleasedJan 6, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
American Society of Clinical Oncology Central Nervous System Tumors (Oral Abstract Session) – 2026 ASCO Annual Meeting
-
American Society of Neuroradiology Primary Melanocytic Tumors of the Central Nervous System in Children: Imaging Features with Pathologic Correlation
-
National Comprehensive Cancer Network Recorded Presentation of NCCN Optimizing Patient Outcomes – From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers
